Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Neurovascular Devices Market Research Report Information By Product (Aneurysm Coiling & Embolization Devices, Support Device), Therapeutic Application (Hemorrhagic & Ischemic Strokes) and End-User (Hospitals, Ambulatory Surgical Units) - Forecast till 2030


ID: MRFR/MED/4096-CR | 173 Pages | Author: Rahul Gotadki| February 2018
Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 Report Prologue

1.1 Introduction 19

1.2 Scope Of Study 19

1.3 Research Objective 19

1.4 Assumptions & Limitations 20

1.4.1 Assumptions 20

1.4.2 Limitations 20

2 Research Methodology

2.1.1 Primary Research Methodology 23

2.1.2 Secondary Research Methodology 24

2.1.3 Market Share Analysis 24

2.1.4 Market Pricing Approach 24

3 Market Dynamics

3.1 Introduction 26

3.2 Drivers 27

3.2.1 Increasing Prevalence Of Neurovascular Diseases Like Brain Aneurysm, Arteriovenous Malformations (AVMs), And Others, Will Propel The Neurovascular Devices Market 27

3.2.2 Favourable Reimbursement Policies Provide Favorable Background For Market Growth 28

3.2.3 Rising Demands For Minimally Invasive Therapeutic Procedures And Growing Geriatric Population Will Drive The Neurovascular Devices Market Growth 29

3.2.4 Ongoing Product Development & Commercialization Will Boost The Neurovascular Devices Market 30

3.3 Restraints 31

3.3.1 High Procedural Cost By Neurovascular Devices 31

3.3.2 Cases Of Injury And Need For Physician Training 32

3.4 Opportunity 33

3.5 Mega Trend 33

3.5.1.1 Increasing Use Of Endovascular Embolization For The Treatment Of Brain Aneurysm 33

3.6 Macroeconomic Indicators 33

4 Market Factor Analysis

4.1 Value Chain Analysis 35

4.1.1 R&D And Designing 35

4.1.2 Manufacturing 36

4.1.3 Distribution & Sales 36

4.1.4 Post-Sales Review 36

4.2 Porter’s Five Forces Model 37

4.2.1 Bargaining Power Of Suppliers 38

4.2.2 Bargaining Power Of Buyers 38

4.2.3 Threat Of New Entrants 38

4.2.4 Threat Of Substitutes 38

4.2.5 Intensity Of Rivalry 38

4.3 Investment Opportunities 38

4.4 Pricing Analysis 39

4.5 Demand & Supply: Gap Analysis 39

5 Neurovascular Devices Market, By Product

5.1 Introduction 41

5.1.1 Aneurysm Coiling & Embolization Devices 43

5.1.1.1 Embolic Coils 43

5.1.1.1.1 Detachable Coils 44

5.1.1.1.2 Pushable Coils 44

5.1.1.2 Flow Diversion Devices 45

5.1.1.3 Liquid Embolic 45

5.1.2 Neurothrombectomy Devices 45

5.1.2.1 Retrieval Systems 46

5.1.2.2 Suction And Aspiration Devices 46

5.1.3 Support Device 47

5.1.3.1 Microcatheters 47

5.1.3.2 Microguidewires 48

5.1.4 Cerebral Balloon Angioplasty And Stenting Systems 48

5.1.4.1 Carotid Artery Stents 49

5.1.4.2 Embolic Protection Systems 49

5.1.4.2.1 Balloon Occlusion Devices 50

5.1.4.2.2 Distal Filter Devices 50

6 Neurovascular Devices Market, By Therapeutic Application

6.1 Introduction 52

6.1.1 Hemorrhagic Stroke 53

6.1.2 Ischemic Strokes 53

7 Neurovascular Devices Market, By End User

7.1 Introduction 55

7.1.1 Hospitals & Clinics 56

7.1.2 Ambulatory Surgical Units 56

8 Global Neurovascular Devices Market, By Region

8.1 Introduction 58

8.2 Americas 59

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.2.1 North America 63

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.2.1.1 U.S. 67

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.2.1.2 Canada 71

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.2.2 South America 74

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.3 Europe 77

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.3.1 Western Europe 82

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.3.1.1 Germany 86

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.3.1.2 France 89

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.3.1.3 U.K 92

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.3.1.4 Italy 95

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.3.1.5 Spain 98

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.3.1.6 Rest Of Western Europe 101

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.3.2 Eastern Europe 104

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.4 Asia Pacific 108

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.4.1 Japan 113

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.4.2 China 116

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.4.3 India 119

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.4.4 Australia 122

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.4.5 Republic Of Korea 125

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.4.6 Rest Of Asia Pacific 128

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.5 Middle East & Africa 131

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.5.1 United Arab Emirates 136

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.5.2 Saudi Arabia 139

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.5.3 Oman 142

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.5.4 Kuwait 145

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.5.5 Qatar 148

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

8.5.6 Rest Of Middle East & Africa 151

Neurovascular Devices Market, By Product

Neurovascular Devices Market, By Therapeutic Application

Neurovascular Devices Market, By End User

9 Company Landscape

9.1 Company Share Analysis 155

10 Company Profiles

10.1 Stryker 157

10.1.1 Company Overview 157

10.1.2 Financials 157

10.1.3 Products 157

10.1.4 Strategy 157

10.1.5 Key Developments 157

10.2 Medtronic 158

10.2.1 Company Overview 158

10.2.2 Financials 158

10.2.3 Products 158

10.2.4 Strategy 158

10.2.5 Key Developments 158

10.3 Johnson & Johnson Services, Inc 159

10.3.1 Company Overview 159

10.3.2 Financials 159

10.3.3 Products 159

10.3.4 Strategy 159

10.3.5 Key Developments 159

10.4 TERUMO CORPORATION 160

10.4.1 Company Overview 160

10.4.2 Financials 160

10.4.3 Products 160

10.4.4 Strategy 160

10.4.5 Key Developments 160

10.5 Abbott 161

10.5.1 Company Overview 161

10.5.2 Financials 161

10.5.3 Products 161

10.5.4 Strategy 161

10.5.5 Key Developments 161

10.6 Merit Medical Systems, Inc. 162

10.6.1 Company Overview 162

10.6.2 Financials 162

10.6.3 Products 162

10.6.4 Strategy 162

10.6.5 Key Developments 162

10.7 Medikit Co., Ltd. 163

10.7.1 Company Overview 163

10.7.2 Financials 163

10.7.3 Products 163

10.7.4 Strategy 163

10.7.5 Key Developments 163

10.8 Penumbra, Inc. 164

10.8.1 Company Overview 164

10.8.2 Financials 164

10.8.3 Products 164

10.8.4 Strategy 164

10.8.5 Key Developments 164

10.9 MicroPort Scientific Corporatio 165

10.9.1 Company Overview 165

10.9.2 Financials 165

10.9.3 Products 165

10.9.4 Strategy 165

10.9.5 Key Developments 165

10.10 Evasc 166

10.10.1 Company Overview 166

10.10.2 Financials 166

10.10.3 Products 166

10.10.4 Strategy 166

10.10.5 Key Developments 166

10.11 Rapid Medical 167

10.11.1 Company Overview 167

10.11.2 Financials 167

10.11.3 Products 167

10.11.4 Strategy 167

10.11.5 Key Developments 167

11 Conclusion

11.1 Key Findings 169

11.1.1 CEO’s Viewpoint 169

11.1.2 Key Companies To Watch 169

11.1.3 Prediction Of NEUROVASCULAR Devices Industry 169

12 Appendix

12.1 Discussion Blue Print 171

12.2 References 173

13 List Of Tables

TABLE 1 PRIMARY INTERVIEWS 23

TABLE 2 GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 42

TABLE 3 GLOBAL NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 43

TABLE 4 GLOBAL NEUROVASCULAR DEVICES MARKET FOR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET, BY REGION 2020-2027 (USD MILLION) 43

TABLE 5 GLOBAL NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 43

TABLE 6 GLOBAL NEUROVASCULAR DEVICES MARKET FOR EMBOLIC COILS, BY REGION 2020-2027 (USD MILLION) 44

TABLE 7 GLOBAL NEUROVASCULAR DEVICES MARKET FOR DETACHABLE COILS, BY REGION 2020-2027 (USD MILLION) 44

TABLE 8 GLOBAL NEUROVASCULAR DEVICES MARKET FOR PUSHABLE COILS, BY REGION 2020-2027 (USD MILLION) 44

TABLE 9 GLOBAL NEUROVASCULAR DEVICES MARKET FOR FLOW DIVERSION DEVICES, BY REGION 2020-2027 (USD MILLION) 45

TABLE 10 GLOBAL NEUROVASCULAR DEVICES MARKET FOR LIQUID EMBOLIC, BY REGION 2020-2027 (USD MILLION) 45

TABLE 11 GLOBAL NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 45

TABLE 12 GLOBAL NEUROVASCULAR DEVICES MARKET FOR NEUROTHROMBECTOMY DEVICES, BY REGION 2020-2027 (USD MILLION) 46

TABLE 13 GLOBAL NEUROVASCULAR DEVICES MARKET FOR RETRIEVAL SYSTEMS , BY REGION 2020-2027 (USD MILLION) 46

TABLE 14 GLOBAL NEUROVASCULAR DEVICES MARKET FOR SUCTION AND ASPIRATION DEVICES, BY REGION 2020-2027 (USD MILLION) 46

TABLE 15 GLOBAL NEUROVASCULAR DEVICES MARKET, SUPPORT DEVICES 2020-2027 (USD MILLION) 47

TABLE 16 GLOBAL NEUROVASCULAR DEVICES MARKET FOR SUPPORT DEVICES, BY REGION 2020-2027 (USD MILLION) 47

TABLE 17 GLOBAL NEUROVASCULAR DEVICES MARKET FOR MICROCATHETERS, BY REGION 2020-2027 (USD MILLION) 47

TABLE 18 GLOBAL NEUROVASCULAR DEVICES MARKET FOR MICROGUIDEWIRES, BY REGION 2020-2027 (USD MILLION) 48

TABLE 19 GLOBAL NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 48

TABLE 20 GLOBAL NEUROVASCULAR DEVICES MARKET FOR CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS, BY REGION 2020-2027 (USD MILLION) 48

TABLE 21 GLOBAL NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENTS, BY REGION 2020-2027 (USD MILLION) 49

TABLE 22 GLOBAL NEUROVASCULAR DEVICES MARKET, EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 49

TABLE 23 GLOBAL NEUROVASCULAR DEVICES MARKET FOR EMBOLIC PROTECTION SYSTEMS, BY REGION 2020-2027 (USD MILLION) 49

TABLE 24 GLOBAL NEUROVASCULAR DEVICES MARKET FOR BALLOON OCCLUSION DEVICES, BY REGION 2020-2027 (USD MILLION) 50

TABLE 25 GLOBAL NEUROVASCULAR DEVICES MARKET FOR DISTAL FILTER DEVICES, BY REGION 2020-2027 (USD MILLION) 50

TABLE 26 GLOBAL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 52

TABLE 27 GLOBAL NEUROVASCULAR DEVICES MARKET FOR HEMORRHAGIC STROKE, BY REGION 2020-2027 (USD MILLION) 53

TABLE 28 GLOBAL NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES MARKET, BY REGION 2020-2027 (USD MILLION) 53

TABLE 29 GLOBAL NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 55

TABLE 30 GLOBAL NEUROVASCULAR DEVICES MARKET FOR HOSPITALS & CLINICS MARKET, BY REGION 2020-2027 (USD MILLION) 56

TABLE 31 GLOBAL NEUROVASCULAR DEVICES MARKET FOR AMBULATORY SURGICAL UNITS MARKET, BY REGION 2020-2027 (USD MILLION) 56

TABLE 32 GLOBAL NEUROVASCULAR DEVICESCS MARKET, BY REGION 2020-2027 (USD MILLION) 58

TABLE 33 AMERICAS NEUROVASCULAR DEVICES MARKET, BY REGION 2020-2027 (USD MILLION) 60

TABLE 34 AMERICAS NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 60

TABLE 35 AMERICAS NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 61

TABLE 36 AMERICAS NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2020-2027 (USD MILLION) 61

TABLE 37 AMERICAS NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 61

TABLE 38 AMERICAS NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 62

TABLE 39 AMERICAS NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 62

TABLE 40 AMERICAS NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 62

TABLE 41 AMERICAS NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 63

TABLE 42 AMERICAS NEUROVASCULAR DEVICES, BY END USER 2020-2027 (USD MILLION) 63

TABLE 43 NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2020-2027 (USD MILLION) 63

TABLE 44 NORTH AMERICA NEUROVASCULAR DEVICES, BY PRODUCT 2020-2027 (USD MILLION) 64

TABLE 45 NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 64

TABLE 46 NORTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2020-2027 (USD MILLION) 65

TABLE 47 NORTH AMERICA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 65

TABLE 48 NORTH AMERICA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 65

TABLE 49 NORTH AMERICA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 66

TABLE 50 NORTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 66

TABLE 51 NORTH AMERICA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 66

TABLE 52 NORTH AMERICA NEUROVASCULAR DEVICES, BY END USER 2020-2027 (USD MILLION) 67

TABLE 53 U.S.NEUROVASCULAR DEVICES, BY PRODUCT 2020-2027 (USD MILLION) 67

TABLE 54 U.S.NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 68

TABLE 55 U.S.NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2020-2027 (USD MILLION) 68

TABLE 56 U.S.NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 68

TABLE 57 U.S.NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 69

TABLE 58 U.S.NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 69

TABLE 59 U.S.NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 70

TABLE 60 U.S.NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 70

TABLE 61 U.S.NEUROVASCULAR DEVICES, BY END USER 2020-2027 (USD MILLION) 70

TABLE 62 CANADA NEUROVASCULAR DEVICES, BY PRODUCT 2020-2027 (USD MILLION) 71

TABLE 63 CANADA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 71

TABLE 64 CANADA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2020-2027 (USD MILLION) 71

TABLE 65 CANADA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 72

TABLE 66 CANADA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 72

TABLE 67 CANADA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 72

TABLE 68 CANADA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 73

TABLE 69 CANADA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 73

TABLE 70 CANADA NEUROVASCULAR DEVICES, BY END USER 2020-2027 (USD MILLION) 73

TABLE 71 SOUTH AMERICA NEUROVASCULAR DEVICES, BY PRODUCT 2020-2027 (USD MILLION) 74

TABLE 72 SOUTH AMERICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 74

TABLE 73 SOUTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2020-2027 (USD MILLION) 74

TABLE 74 SOUTH AMERICA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 75

TABLE 75 SOUTH AMERICA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 75

TABLE 76 SOUTH AMERICA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 75

TABLE 77 SOUTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 76

TABLE 78 SOUTH AMERICA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 76

TABLE 79 SOUTH AMERICA NEUROVASCULAR DEVICES, BY END USER 2020-2027 (USD MILLION) 76

TABLE 80 EUROPE NEUROVASCULAR DEVICES MARKET, BY REGION 2020-2027 (USD MILLION) 78

TABLE 81 EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 79

TABLE 82 EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 79

TABLE 83 EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 79

TABLE 84 EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 80

TABLE 85 EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 80

TABLE 86 EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 80

TABLE 87 EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 81

TABLE 88 EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 81

TABLE 89 EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 81

TABLE 90 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2020-2027 (USD MILLION) 82

TABLE 91 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 82

TABLE 92 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 82

TABLE 93 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 84

TABLE 94 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 84

TABLE 95 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 84

TABLE 96 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 85

TABLE 97 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 85

TABLE 98 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 85

TABLE 99 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 86

TABLE 100 GERMANY NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 86

TABLE 101 GERMANY NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 87

TABLE 102 GERMANY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 87

TABLE 103 GERMANY NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 87

TABLE 104 GERMANY NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 88

TABLE 105 GERMANY NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 88

TABLE 106 GERMANY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 88

TABLE 107 GERMANY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 89

TABLE 108 GERMANY NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 89

TABLE 109 FRANCE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 89

TABLE 110 FRANCE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 90

TABLE 111 FRANCE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 90

TABLE 112 FRANCE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 90

TABLE 113 FRANCE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 91

TABLE 114 FRANCE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 91

TABLE 115 FRANCE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 91

TABLE 116 FRANCE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 92

TABLE 117 FRANCE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 92

TABLE 118 U.K NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 92

TABLE 119 U.K NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 93

TABLE 120 U.K NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 93

TABLE 121 U.K NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 93

TABLE 122 U.K NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 94

TABLE 123 U.K NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 94

TABLE 124 U.K NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 94

TABLE 125 U.K NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 95

TABLE 126 U.K NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 95

TABLE 127 ITALY NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 95

TABLE 128 ITALY NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 96

TABLE 129 ITALY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 96

TABLE 130 ITALY NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 96

TABLE 131 ITALY NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 97

TABLE 132 ITALY NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 97

TABLE 133 ITALY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 97

TABLE 134 ITALY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 98

TABLE 135 ITALY NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 98

TABLE 136 SPAIN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 98

TABLE 137 SPAIN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 99

TABLE 138 SPAIN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 99

TABLE 139 SPAIN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 99

TABLE 140 SPAIN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 100

TABLE 141 SPAIN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 100

TABLE 142 SPAIN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 100

TABLE 143 SPAIN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 101

TABLE 144 SPAIN NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 101

TABLE 145 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 101

TABLE 146 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 102

TABLE 147 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 102

TABLE 148 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 102

TABLE 149 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 103

TABLE 150 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 103

TABLE 151 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 103

TABLE 152 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 104

TABLE 153 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 104

TABLE 154 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 104

TABLE 155 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 105

TABLE 156 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 105

TABLE 157 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 105

TABLE 158 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 106

TABLE 159 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 106

TABLE 160 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 106

TABLE 161 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 107

TABLE 162 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 107

TABLE 163 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 107

TABLE 164 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 107

TABLE 165 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2020-2027 (USD MILLION) 109

TABLE 166 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 110

TABLE 167 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 110

TABLE 168 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 110

TABLE 169 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 111

TABLE 170 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 111

TABLE 171 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 111

TABLE 172 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 112

TABLE 173 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 112

TABLE 174 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 112

TABLE 175 JAPAN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 113

TABLE 176 JAPAN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 113

TABLE 177 JAPAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 113

TABLE 178 JAPAN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 114

TABLE 179 JAPAN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 114

TABLE 180 JAPAN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 114

TABLE 181 JAPAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 115

TABLE 182 JAPAN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 115

TABLE 183 JAPAN NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 115

TABLE 184 CHINA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 116

TABLE 185 CHINA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 116

TABLE 186 CHINA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 116

TABLE 187 CHINA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 117

TABLE 188 CHINA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 117

TABLE 189 CHINA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 117

TABLE 190 CHINA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 118

TABLE 191 CHINA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 118

TABLE 192 CHINA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 118

TABLE 193 INDIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 119

TABLE 194 INDIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 119

TABLE 195 INDIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 119

TABLE 196 INDIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 120

TABLE 197 INDIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 120

TABLE 198 INDIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 120

TABLE 199 INDIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 121

TABLE 200 INDIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 121

TABLE 201 INDIA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 121

TABLE 202 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 122

TABLE 203 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 122

TABLE 204 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 122

TABLE 205 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 123

TABLE 206 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 123

TABLE 207 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 123

TABLE 208 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 124

TABLE 209 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 124

TABLE 210 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 124

TABLE 211 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 125

TABLE 212 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 125

TABLE 213 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 125

TABLE 214 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 126

TABLE 215 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 126

TABLE 216 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 126

TABLE 217 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 127

TABLE 218 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 127

TABLE 219 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 127

TABLE 220 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 128

TABLE 221 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 128

TABLE 222 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 128

TABLE 223 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 129

TABLE 224 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 129

TABLE 225 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 129

TABLE 226 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 130

TABLE 227 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 130

TABLE 228 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 130

TABLE 229 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2020-2027 (USD MILLION) 132

TABLE 230 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 133

TABLE 231 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 133

TABLE 232 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 133

TABLE 233 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 134

TABLE 234 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 134

TABLE 235 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 134

TABLE 236 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 135

TABLE 237 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLUICATION 2020-2027 (USD MILLION) 135

TABLE 238 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY END USERM 2020-2027 (USD MILLION) 135

TABLE 239 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 136

TABLE 240 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 136

TABLE 241 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 136

TABLE 242 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 137

TABLE 243 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 137

TABLE 244 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 137

TABLE 245 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 138

TABLE 246 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 138

TABLE 247 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 138

TABLE 248 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 139

TABLE 249 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 139

TABLE 250 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 139

TABLE 251 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 140

TABLE 252 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 140

TABLE 253 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 140

TABLE 254 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 141

TABLE 255 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 141

TABLE 256 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 141

TABLE 257 OMAN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 142

TABLE 258 OMAN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 142

TABLE 259 OMAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 142

TABLE 260 OMAN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 143

TABLE 261 OMAN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 143

TABLE 262 OMAN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 143

TABLE 263 OMAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 144

TABLE 264 OMAN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 144

TABLE 265 OMAN NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 144

TABLE 266 KUWAIT NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 145

TABLE 267 KUWAIT NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 145

TABLE 268 KUWAIT NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 145

TABLE 269 KUWAIT NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 146

TABLE 270 KUWAIT NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 146

TABLE 271 KUWAIT NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 146

TABLE 272 KUWAIT NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 147

TABLE 273 KUWAIT NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 147

TABLE 274 KUWAIT NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 147

TABLE 275 QATAR NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 148

TABLE 276 QATAR NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 148

TABLE 277 QATAR NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 148

TABLE 278 QATAR NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 149

TABLE 279 QATAR NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 149

TABLE 280 QATAR NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 149

TABLE 281 QATAR NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 150

TABLE 282 QATAR NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 150

TABLE 283 QATAR NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 150

TABLE 284 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 151

TABLE 285 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 151

TABLE 286 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 151

TABLE 287 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 152

TABLE 288 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 152

TABLE 289 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 152

TABLE 290 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 153

TABLE 291 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 153

TABLE 292 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION)

153

14 List Of Figures

FIGURE 1 GLOBAL NEUROVASCULAR DEVICES: MARKET STRUCTURE 20

FIGURE 2 RESEARCH METHODOLOGY 22

FIGURE 3 GLOBAL NEUROVASCULAR DEVICES MARKET: FORECAST MODEL 24

FIGURE 4 VALUE CHAIN: NEUROVASCULAR DEVICES MARKET 35

FIGURE 5 PORTERS FIVE FORCES MODEL: GLOBAL NEUROVASCULAR DEVICES MARKET 37

FIGURE 6 GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020 & 2027 (USD MILLION) 42

FIGURE 7 GLOBAL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 52

FIGURE 8 GLOBAL NEUROVASCULAR DEVICES MARKET, BY END USER 2020 & 2027 (USD MILLION) 55

FIGURE 9 GLOBAL NEUROVASCULAR DEVICES MARKET, BY REGION 2020 & 2027 (USD MILLION) 58

FIGURE 10 AMERICAS NEUROVASCULAR DEVICES MARKET SHARE, BY REGION 2020 (%) 60

FIGURE 11 EUROPE NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 78

FIGURE 12 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 109

FIGURE 13 MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 132

FIGURE 14 GLOBAL NEUROVASCULAR DEVICES MARKET COMPANY SHARE ANALYSIS, 2020 (%) 155

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.